BICLUSTER_ID : DNREG-160
PATHOGENS /4/ : pseudomonas aeruginosa,escherichia coli,lactobacillus acidophilus,helicobacter pylori
TARGETS /19/ : TGFBR2, NNT, MGST3, HPRT1, MAPK14, IARS2, FARS2, AURKA, NDUFB5, ACADM, ACAT1, PARP1, ME2, HADH, MUT, SLC25A5, IDH1, MCM6, NDUFS2
Gene SetLeading Edge Genes
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPELOVL6, MLH1, MGST3, HPRT1, FARS2, IARS2, AURKA, ANKMY2, HTATSF1, NDUFB5, RPA3, SMC3, SLC9A6, MSH6, WRB, PARP1, IDH1, MDC1, DDX46, RCN2
STEIN ESRRA TARGETS UPNNT, ATP5C1, TRAK2, MGST3, ORC2L, AURKA, NDUFB5, CALU, ACADM, ACAA2, TRIM2, COQ9, ACAT1, PGM1, MUT, NDUFS2, ACYP1, SAMM50, MIPEP, EBP
BUYTAERT PHOTODYNAMIC THERAPY STRESS DNTGFBR2, BUB1, ELOVL6, MAPK14, AURKA, PARP2, B3GNT1, TOP2A, ZDHHC3, ID1, LANCL1, CDKN2C, VCL, HADH, POLE2, HHEX, EBP
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DNCCNB2, MAD2L1, MSH2, ME2, POLE2, SLC25A5, RNASEH2A, PRPS1, RPA3, RFC5, RCN2
RHODES UNDIFFERENTIATED CANCERMAD2L1, KIF23, CCNB1, CENPA, MCM6, TOP2A, KIF2C, TRIP13
NCI PLK1 PATHWAYAURKA, BUB1B, BUB1, CDC25C, CCNB1
KAUFFMANN MELANOMA RELAPSE UPMCM6, MSH6, MAD2L1, MSH2, RPA3, RFC5, TOP2A, CENPF
KEGG CELL CYCLEBUB1B, TTK, CCNB2, MAD2L1, CDKN2C, BUB1, CDC25C, ORC2L, CCNB1, MCM6, SMC3, PRKDC
BENPORATH MYC MAX TARGETS
BOYAULT LIVER CANCER SUBCLASS G123 UP
REACTOME CELL CYCLE CHECKPOINTS
KUMAMOTO RESPONSE TO NUTLIN 3A DN
STEIN ESRRA TARGETS
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
WAESCH ANAPHASE PROMOTING COMPLEX
REACTOME PEROXISOMAL LIPID METABOLISM
NCI REPAIR SYNTHESIS FOR GAP FILLING BY DNA POLYMERASE IN TC NER
NCI CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION
NCI MITOTIC PROMETAPHASEBUB1B, SMC3, BUB1, KIF2C, CENPA
NCI CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
REACTOME CHOLESTEROL BIOSYNTHESIS
BOYAULT LIVER CANCER SUBCLASS G23 UP
KEGG MISMATCH REPAIR
CORUM DNA SYNTHESOME COMPLEX 13 SUBUNITS
SENESE HDAC3 TARGETS DN
REACTOME SYNTHESIS OF DNA
VALK AML CLUSTER 15
KAUFFMANN DNA REPAIR GENES
REACTOME DNA REPLICATION PRE INITIATION
REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
CORUM BASC AB 80 COMPLEX BRCA1-ASSOCIATED GENOME SURVEILLANCE COMPLEX
GEORGES TARGETS OF MIR192 AND MIR215
CORUM BASC COMPLEX BRCA1-ASSOCIATED GENOME SURVEILLANCE COMPLEX
MORI EMU MYC LYMPHOMA BY ONSET TIME UP
GOLDRATH ANTIGEN RESPONSE
NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
CHEMNITZ RESPONSE TO PROSTAGLANDIN E2 UP
KEGG PEROXISOME
BENPORATH CYCLING GENES
NCI SNRNP ASSEMBLY
DING LUNG CANCER EXPRESSION BY COPY NUMBER
CORUM DNA SYNTHESOME COMPLEX 17 SUBUNITS
WAKASUGI HAVE ZNF143 BINDING SITES
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN
KEGG OOCYTE MEIOSIS
KEGG PROPANOATE METABOLISM
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
NCI PROPIONYL COA CATABOLISM
RICKMAN METASTASIS UP
FINETTI BREAST CANCER BASAL VS LUMINAL
BIOCARTA PTC1 PATHWAY
WEST ADRENOCORTICAL TUMOR UP
CORUM PCNA-MUTS-ALPHA-MUTL-ALPHA-DNA COMPLEX
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UPKIF23, POLE2, CCNB1, ARHGAP11A, RPA3, TOP2A, CENPF, KIF2C
ZHONG RESPONSE TO AZACITIDINE AND TSA DN
REACTOME G1 S TRANSITION
REACTOME S PHASE
FINETTI BREAST CANCER KINOME RED
MOREAUX MULTIPLE MYELOMA BY TACI DN
VANTVEER BREAST CANCER METASTASIS DN
KIM WT1 TARGETS DN
SONG TARGETS OF IE86 CMV PROTEIN
KEGG PROGESTERONE MEDIATED OOCYTE MATURATION
KEGG NUCLEOTIDE EXCISION REPAIR
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx2 npgeclactobacillus acidophiluspseudomonas aeruginosaescherichia coliGeneSet Name
-0.00489 -0.00129 -0.01279 -0.03431ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00631 -0.00073 -0.06554 -0.08961STEIN_ESRRA_TARGETS_UP
-0.00546 -0.00008 -0.03826 -0.02439BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
-0.00042 -0.00561 -0.00006 -0.01548CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
-0.00065 -0.00080 -0.02924 -0.01515RHODES_UNDIFFERENTIATED_CANCER
-0.00213 -0.00001 -0.01327 -0.00006NCI_PLK1_PATHWAY
-0.00390 -0.00009 -0.00004 -0.00005KAUFFMANN_MELANOMA_RELAPSE_UP
-0.00787 -0.00055 -0.00226 -0.01211KEGG_CELL_CYCLE
-0.00219 -0.01279 -0.08688 -0.12362BENPORATH_MYC_MAX_TARGETS
-0.06351 -0.09604 -0.01718 -0.02103BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
-0.00003 -0.00613 -0.00423 -0.03627REACTOME_CELL_CYCLE_CHECKPOINTS
-0.04464 -0.00892 -0.07193 -0.00055KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.00737 -0.00110 -0.08662 -0.16117STEIN_ESRRA_TARGETS
-0.03797 -0.12158 -0.08242 -0.00010THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
-0.07316 -0.19798 -0.04714 -0.09555WAESCH_ANAPHASE_PROMOTING_COMPLEX
-0.00494 -0.00884 -0.07680 -0.02116REACTOME_PEROXISOMAL_LIPID_METABOLISM
-0.01553 -0.00254 -0.18027 -0.00127NCI_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POLYMERASE_IN_TC_NER
-0.14068 -0.01573 -0.14694 -0.17317NCI_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
-0.00583 -0.00003 -0.00094 -0.00007NCI_MITOTIC_PROMETAPHASE
-0.02559 -0.11267 -0.10992 -0.08967NCI_CHK1_CHK2_CDS1__MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX
-0.01585 -0.00604 -0.18726 -0.01316REACTOME_CHOLESTEROL_BIOSYNTHESIS
-0.17014 -0.00067 -0.17995 -0.00057BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
-0.02889 -0.00004 -0.13621 -0.00033KEGG_MISMATCH_REPAIR
-0.10675 -0.00268 -0.19900 -0.03605CORUM_DNA_SYNTHESOME_COMPLEX_13_SUBUNITS
-0.01982 -0.14624 -0.14639 -0.02211SENESE_HDAC3_TARGETS_DN
-0.00016 -0.03098 -0.12476 -0.17829REACTOME_SYNTHESIS_OF_DNA
-0.02976 -0.07647 -0.09034 -0.16755VALK_AML_CLUSTER_15
-0.09101 -0.00009 -0.04560 -0.00003KAUFFMANN_DNA_REPAIR_GENES
-0.00061 -0.01571 -0.08852 -0.19797REACTOME_DNA_REPLICATION_PRE_INITIATION
-0.05807 -0.00068 -0.14211 -0.03446REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.14772 -0.06130 -0.04581 -0.01201CORUM_BASC_AB_80_COMPLEX_BRCA1-ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX
-0.02831 -0.10556 -0.01016 -0.12214GEORGES_TARGETS_OF_MIR192_AND_MIR215
-0.03121 -0.05382 -0.09605 -0.13860CORUM_BASC_COMPLEX_BRCA1-ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX
-0.09503 -0.02388 -0.04215 -0.01552MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
-0.02222 -0.00286 -0.11188 -0.09190GOLDRATH_ANTIGEN_RESPONSE
-0.00718 -0.00124 -0.12550 -0.03360NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.01724 -0.00001 -0.18697 -0.01416CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP
-0.04060 -0.10237 -0.17007 -0.00379KEGG_PEROXISOME
-0.02705 -0.00012 -0.01705 -0.00035BENPORATH_CYCLING_GENES
-0.07564 -0.00028 -0.16868 -0.18300NCI_SNRNP_ASSEMBLY
-0.07293 -0.19751 -0.00113 -0.06348DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
-0.06173 -0.00058 -0.07338 -0.01981CORUM_DNA_SYNTHESOME_COMPLEX_17_SUBUNITS
-0.13870 -0.00168 -0.19894 -0.00048WAKASUGI_HAVE_ZNF143_BINDING_SITES
-0.05828 -0.11023 -0.11040 -0.04179LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
-0.00681 -0.05740 -0.00045 -0.06347KEGG_OOCYTE_MEIOSIS
-0.01525 -0.02277 -0.03223 -0.00176KEGG_PROPANOATE_METABOLISM
-0.04603 -0.06171 -0.00868 -0.05317RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.19463 -0.05507 -0.19479 -0.16535NCI_PROPIONYL_COA_CATABOLISM
-0.09744 -0.02371 -0.00225 -0.01546RICKMAN_METASTASIS_UP
-0.03351 -0.00058 -0.12915 -0.00339FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL
-0.08924 -0.05026 -0.10980 -0.12805BIOCARTA_PTC1_PATHWAY
-0.00769 -0.00173 -0.01510 -0.10340WEST_ADRENOCORTICAL_TUMOR_UP
-0.16923 -0.01566 -0.13369 -0.08403CORUM_PCNA-MUTS-ALPHA-MUTL-ALPHA-DNA_COMPLEX
-0.01181 -0.00030 -0.05357 -0.00253FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
-0.01265 -0.01392 -0.10608 -0.01151ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
-0.00214 -0.00092 -0.05329 -0.15306REACTOME_G1_S_TRANSITION
-0.00017 -0.00260 -0.10989 -0.17828REACTOME_S_PHASE
-0.02908 -0.00052 -0.09937 -0.00394FINETTI_BREAST_CANCER_KINOME_RED
-0.10216 -0.01167 -0.01021 -0.02459MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
-0.11662 -0.00002 -0.00024 -0.00298VANTVEER_BREAST_CANCER_METASTASIS_DN
-0.03111 -0.02088 -0.00054 -0.00121KIM_WT1_TARGETS_DN
-0.08199 -0.00393 -0.13343 -0.00020SONG_TARGETS_OF_IE86_CMV_PROTEIN
-0.00440 -0.13731 -0.13358 -0.07096KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
-0.15205 -0.00448 -0.03758 -0.00032KEGG_NUCLEOTIDE_EXCISION_REPAIR